DEC 26, 2018 8:26 PM PST

New Blood Pressure Target

WRITTEN BY: Nouran Amin

According to a study published in eLife, researchers concluded that a protein channel may serve as an effective target for blood pressure regulation. Targeting the channel in mice was found to reduce blood pressure. The study sheds new light on developing new drugs for the treatment of high blood pressure, a condition that serves as the leading cause of heart attack and stroke.

Learn more about blood pressure:

In general, blood pressure is influenced by muscles cells that line the walls of the arteries. These muscle cells include proteins in their surface called Transient Receptor Potential (TRP) channels which regulate the movement of sodium and calcium ions. The role of TRP in high blood pressure still remains unclear, however, 13 different TRP channels were confirmed to be present on the muscle cells lining the arteries.

"The contribution of TRP channels to normal blood pressure and to changes in blood pressure are unclear, and we don't know whether the different channel types in different organs are controlled in a similar way," states senior author of the study Jonathan Jaggar. "We chose to study a TRP channel called PKD2 because patients with genetic mutations in this protein have high blood pressure and previous research has shown conflicting results regarding its functions in arterial muscle cells."

Image Retrieved From Unsplash.com

The targeting of PKD2 in mice was found to lower blood pressure than normal mice. "Our results indicate that stimuli which activate PKD2 channels are blood vessel specific, showing that there is not a singular mechanism regulating muscle cell contractility in all arteries," concludes Jaggar. "Our demonstration that muscle cell PKD2 channels regulate blood pressure is a step forward to better understanding the importance of this ion channel target in normal cardiovascular physiology, and as a potential drug target for cardiovascular disease."

Source: eLife

 

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 19, 2019
Drug Discovery & Development
NOV 19, 2019
Psychedelic DMT Creates Vivid Waking Dream State in Brain
In a new study, scientists at Imperial College London investigated how powerful psychedelic dimethyltryptamine (DMT) alters the brain’s electrical ac...
NOV 23, 2019
Drug Discovery & Development
NOV 23, 2019
Drug Seeks To Target Treatment-Resistant Epilepsy
Ever imagined a world where you cannot shower alone, drive by yourself, and even go to work in fear of having the next seizure that can incapacitate you? U...
DEC 23, 2019
Drug Discovery & Development
DEC 23, 2019
FDA Approves New Schizophrenic Drug
The US Food and Drug Administration (FDA) has approved an atypical antipsychotic Caplyta (lumateperone; Intra-Cellular Therapies) for the treating schizoph...
JAN 09, 2020
Drug Discovery & Development
JAN 09, 2020
Can Cancer Drugs Treat Lung Damage?
Can therapeutics used in the treatment of cancer be a breakthrough for pulmonary disease? Specifically, chronic obstructive pulmonary disease (COPD)? &ldqu...
FEB 11, 2020
Cannabis Sciences
FEB 11, 2020
Traffic Light System Best Way to Label Cannabis Edibles
Cannabis products have become increasingly popular. Yet, as they are still relatively new to the market, research has found that most consumers don’t...
FEB 08, 2020
Drug Discovery & Development
FEB 08, 2020
Drug Targets Brain-Eating Amoebas
Brain-eating amoebas lead to high rates of mortality as a result of encephalitis. In fact, more than 95% of people who develop the infection will die. Unfo...
Loading Comments...